Community Awareness

Cure SMA Joins SMA Europe and TREAT-NMD for Meeting with EMA Regulators

November 10, 2016
Posted in , ,

Cure SMA will be participating in a one-day workshop with The European Medicines Agency (EMA—the European equivalent of the FDA), SMA Europe and TREAT-NMD to […]

Read More ›

Cure SMA to Host Webinar on the New Drug Application Process

November 9, 2016
Posted in , , ,

On Tuesday, December 6, Cure SMA will be hosting a one-hour webinar on the New Drug Application (NDA) process. The webinar will be held at […]

Read More ›

SMA Community is Granted a Patient Focused Drug Development Meeting with the FDA

October 19, 2016
Posted in , , ,

Cure SMA is excited to announce that the SMA community has been granted a Patient Focused Drug Development Meeting with the FDA. At the Patient […]

Read More ›

Cure SMA and Ionis Announce 2016 Holiday Card Contest

October 13, 2016
Posted in ,

Back by popular demand, Cure SMA and Ionis Pharmaceuticals are once again teaming up for a holiday card contest! This contest is open to children […]

Read More ›

Cure SMA Announces Newborn Screening Initiative in Partnership with MDA

September 27, 2016
Posted in , , ,

Twice this year, Cure SMA has had the opportunity to testify before the federal Advisory Committee on Heritable Disorders on the need for newborn screening […]

Read More ›

Cure SMA Welcomes Aboard New Board and Committee Members

September 13, 2016
Posted in , ,

Recently, Cure SMA confirmed three new board members and one new committee member. These new members will provide additional leadership in the areas of advocacy, […]

Read More ›

We’re Partnering With The Mighty!

September 2, 2016
Posted in , , ,

We’re thrilled to announce a new partnership that will bring Cure SMA’s resources in front of The Mighty‘s wide-reaching readership. We will now have a […]

Read More ›

Cure SMA Plans a Series of Educational Modules for the SMA Community

August 18, 2016
Posted in , , , ,

With the recent news that Biogen and Ionis will submit nusinersen for FDA approval—along with other recent developments, including the breakthrough designation for AveXis’s gene […]

Read More ›

Cure SMA Releases Full Schedule for the 2016 Annual SMA Conference

May 19, 2016
Posted in , , ,

Cure SMA has released the full schedule for the 2016 Annual SMA Conference, which will be held in Anaheim, CA at Disneyland, June 16-19. The […]

Read More ›

Cure SMA Welcomes New Board and Committee Members

April 29, 2016
Posted in , ,

Recently, Cure SMA confirmed three new board members and several new committee members. These new members will provide additional leadership in the areas of advocacy, […]

Read More ›
Scroll to Top